Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Systemic glucocorticoids (e.g., prednisone, methylprednisolone) remain the first-line therapy for Acute graft-versus-host disease (acute GVHD), typically initiated at 2 mg/kg/day equivalents. However, retrospective and prospective studies suggest lower doses (1 mg/kg/day) may be equally effective for grades I-II disease without compromising survival or disease control.
…